KATHERINE ATWOOD: Open Payments
NPI 1376900084 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,533 in 82 payments from 13 companies in 2025. Trend: 2023 $1,682 · 2024 $1,922 · 2025 $2,533
Food & beverage: $1,568Consulting: $900Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $1,187 |
| UCB, Inc. | 13 | $297 |
| ABBVIE INC. | 11 | $232 |
| Galderma Laboratories, L.P. | 8 | $188 |
| Regeneron Healthcare Solutions, Inc. | 5 | $139 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $96 |
| Amgen Inc. | 3 | $67 |
| Organon LLC | 9 | $58 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, SKYRIZI, DUPIXENT, Sotyktu, RINVOQ, COSENTYX.
Industry payments across FL — which companies pay providers there.
